Leerink Partnrs Comments on McKesson Co.'s Q2 2025 Earnings (NYSE:MCK)

McKesson Co. (NYSE:MCK - Free Report) - Equities research analysts at Leerink Partnrs lowered their Q2 2025 earnings estimates for McKesson in a report released on Monday, October 7th. Leerink Partnrs analyst M. Cherny now expects that the company will post earnings per share of $6.85 for the quarter, down from their previous estimate of $6.89. The consensus estimate for McKesson's current full-year earnings is $32.07 per share. Leerink Partnrs also issued estimates for McKesson's Q3 2025 earnings at $8.54 EPS and Q4 2025 earnings at $8.81 EPS.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $7.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.21 by $0.67. The company had revenue of $79.28 billion for the quarter, compared to analyst estimates of $82.53 billion. McKesson had a net margin of 0.94% and a negative return on equity of 242.57%. The business's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the firm posted $7.27 earnings per share.

A number of other analysts have also issued reports on the stock. Baird R W lowered shares of McKesson from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, September 24th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of McKesson from $623.00 to $579.00 and set a "buy" rating for the company in a research report on Wednesday, September 25th. Mizuho raised their price target on shares of McKesson from $540.00 to $570.00 and gave the stock a "neutral" rating in a research report on Thursday, August 8th. StockNews.com downgraded shares of McKesson from a "buy" rating to a "hold" rating in a research report on Friday, September 27th. Finally, Evercore ISI decreased their price objective on shares of McKesson from $660.00 to $630.00 and set an "outperform" rating for the company in a report on Thursday, August 8th. Five analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $610.86.

McKesson Stock Up 2.4 %

Shares of MCK traded up $11.42 during mid-day trading on Tuesday, reaching $495.09. 771,618 shares of the stock traded hands, compared to its average volume of 809,612. The firm has a market cap of $64.33 billion, a price-to-earnings ratio of 21.81, a P/E/G ratio of 1.18 and a beta of 0.44. The stock has a fifty day simple moving average of $538.27 and a 200 day simple moving average of $554.00. McKesson has a 12-month low of $431.35 and a 12-month high of $637.51.

McKesson Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, October 1st. Stockholders of record on Monday, September 2nd were issued a dividend of $0.71 per share. This is an increase from McKesson's previous quarterly dividend of $0.62. The ex-dividend date of this dividend was Friday, August 30th. This represents a $2.84 annualized dividend and a dividend yield of 0.57%. McKesson's payout ratio is 12.69%.

Insider Activity

In related news, CEO Brian S. Tyler sold 3,753 shares of McKesson stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $626.03, for a total transaction of $2,349,490.59. Following the sale, the chief executive officer now directly owns 82,339 shares in the company, valued at $51,546,684.17. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.11% of the company's stock.

Institutional Investors Weigh In On McKesson

A number of hedge funds and other institutional investors have recently modified their holdings of MCK. LRI Investments LLC bought a new stake in McKesson in the first quarter worth about $28,000. Register Financial Advisors LLC bought a new stake in McKesson in the first quarter worth about $29,000. Richardson Financial Services Inc. bought a new stake in McKesson in the fourth quarter worth about $31,000. Rise Advisors LLC bought a new stake in McKesson in the first quarter worth about $40,000. Finally, ZRC Wealth Management LLC bought a new stake in McKesson in the first quarter worth about $48,000. 85.07% of the stock is currently owned by institutional investors.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.